AADAC Antibody (C-term) Blocking Peptide
€363.00
In stock
SKU
AC-BP6805b
Background:
Arylacetamide deacetylation is an important enzyme activity in the metabolic activation of arylamine substrates to ultimate carcinogens.
Other Names:
Arylacetamide deacetylase, AADAC, DAC
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP6805b was selected from the C-term region of human AADAC. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: AADAC
Gene ID: 13
Primary Accession: P22760
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Arylacetamide deacetylation is an important enzyme activity in the metabolic activation of arylamine substrates to ultimate carcinogens.
Other Names:
Arylacetamide deacetylase, AADAC, DAC
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP6805b was selected from the C-term region of human AADAC. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: AADAC
Gene ID: 13
Primary Accession: P22760
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review